Alberta does not have direct flights to China, which should cut down the risk of an outbreak here, say experts.
Despite the World Health Organization declaring a global health emergency, Alberta health officials are reaffirming that local risk from novel coronavirus remains low.
Alberta’s chief medical officer, Dr. Deena Hinshaw, said Thursday that screening tests have still not resulted in any probable or confirmed cases of the virus in the province.
“The cases that we’ve seen in Canada are all travel-related and measures have been taken to isolate them and prevent infection from spreading,” Hinshaw said. “At this time, the risk to Albertans is still considered to be low, even though the World Health Organization has made this declaration.”
No immediate changes to Alberta’s approach will be made, Hinshaw said. She notes that the virus’s risk is lower in the province than elsewhere in the country because there are no direct flights from China to Alberta airports.
Hinshaw was not able to confirm the number of people the province had tested for coronavirus to date.
The WHO’s Thursday decision to declare coronavirus a global health emergency comes as the number of confirmed cases worldwide climbs over 9,400, with 212 deaths from the virus.
There have been three confirmed or presumptive positive coronavirus cases in Canada, including in British Columbia. That province’s public health officials said Monday a Vancouver-area man who had recently returned from a business trip to Wuhan, China, the centre of the outbreak, had tested positive after experiencing symptoms of the virus.
The federal government is preparing a charter flight to bring healthy Canadians stranded in China home. Hinshaw says the province is working with federal officials on the repatriation effort but details are scarce, including how many Albertans will be returning.
“We haven’t yet heard specifically those people will be brought back, when they will land and what those next steps will be,” Hinshaw said. “When we do get that information, we will be happy to share it.”
Some local agencies and schools with ties to China have reacted to the coronavirus breakout by cancelling travel or business plans.
The University of Calgary said Thursday it has suspended all university-related travel to China, including for seven students who were previously scheduled to study abroad there this semester.
“In order to protect the safety and well-being of UCalgary students, faculty and staff, the university is taking this precautionary measure and will continue to monitor for any new developments and will adjust our protocols as required,” the school said in a statement.
The U of C is also helping to make travel arrangements for three of its members — an undergraduate student, a graduate student and a faculty member — currently in Beijing.
In Edmonton, the University of Alberta is similarly cancelling or postponing all non-essential travel to China. The school has two students currently studying abroad in China, but that they are each in regions unaffected by coronavirus and are known to be safe.
A spring break trip to Beijing for students at Webber Academy has also been cancelled. It’s the first time the school has ever had to cancel one of its trips abroad, which are part of its language programs, said Barbara Webber, the academy’s vice-president administration.
“We had 36 children signed up for that trip, as well as four chaperones,” Webber said. “A couple weeks ago we decided we wouldn’t be going because there were just too many unanswered questions, even if things improved right away.”
Travel Alberta, which promotes the province as a tourist destination in China, has suspended its marketing in the country until further notice.
“We are aware of some trip cancellations,” said Travel Alberta CEO Royce Chwin in a statement. “However, it’s too early to know what impact this will have on Alberta tourism. We are monitoring the situation and will keep in touch with our industry partners.
“We are asking partners to accept tour cancellation requests and offer refunds to Chinese visitors to assist them during a difficult time. This is an exceptional circumstance that goes beyond tourism.”
The Southern Alberta Institute of Technology tweeted that a “coronavirus-related” hoax took place on the school’s campus Thursday afternoon, with police investigating the incident.
“It looks like it was a prank that happened earlier with some people running through with Hazmat suits,” said SAIT associate director of communications Chris Gerritsen. “There’s lots of hoaxes around, there’s lots of disinformation around. In this time of heightened emotions around it, there’s no place for pranks like that.”
Hinshaw said she understands many Albertans may be feeling anxious about the health threat and said it’s important people get their information from reliable sources.
Coronavirus is a respiratory virus that has symptoms of a runny nose, fever, sore throat or coughing. Though a case of person-to-person transmission has been confirmed in the United States, coronavirus is most likely in those with a history of travel to Wuhan or who has been in close contact with a person who has recently travelled to Wuhan.
If any Albertans have specific concerns about exposure to or symptoms of coronavirus, Hinshaw recommends they call the Health Link hotline at 811.
Ultra-Processed Foods May Be Linked to Increased Risk of Cancer
Summary: High consumption of ultra-processed foods, including soda, chips, and some white bread products, was associated with an increased risk of developing and dying from certain kinds of cancer, including brain cancer.
Source: Imperial College London
Higher consumption of ultra-processed foods may be linked to an increased risk of developing and dying from cancer, an Imperial College London-led observational study suggests.
Researchers from Imperial’s School of Public Health have produced the most comprehensive assessment to date of the association between ultra-processed foods and the risk of developing cancers.
Ultra-processed foods are food items which have been heavily processed during their production, such as fizzy drinks, mass-produced packaged breads, many ready meals and most breakfast cereals.
Ultra-processed foods are often relatively cheap, convenient, and heavily marketed, often as healthy options. But these foods are also generally higher in salt, fat, sugar, and contain artificial additives. It is now well documented that they are linked with a range of poor health outcomes including obesity, type 2 diabetes and cardiovascular disease.
The first UK study of its kind used UK Biobank records to collect information on the diets of 200,000 middle-aged adult participants. Researchers monitored participants’ health over a 10-year period, looking at the risk of developing any cancer overall as well as the specific risk of developing 34 types of cancer. They also looked at the risk of people dying from cancer.
The study found that higher consumption of ultra-processed foods was associated with a greater risk of developing cancer overall, and specifically with ovarian and brain cancers. It was also associated with an increased risk of dying from cancer, most notably with ovarian and breast cancers.
For every 10 percent increase in ultra-processed food in a person’s diet, there was an increased incidence of 2 percent for cancer overall, and a 19 percent increase for ovarian cancer specifically.
Each 10 percent increase in ultra-processed food consumption was also associated with increased mortality for cancer overall by 6 percent, alongside a 16 percent increase for breast cancer and a 30 percent increase for ovarian cancer.
These links remained after adjusting for a range of socio-economic, behavioral and dietary factors, such as smoking status, physical activity and body mass index (BMI).
The Imperial team carried out the study, which is published in eClinicalMedicine, in collaboration with researchers from the International Agency for Research on Cancer (IARC), University of São Paulo, and NOVA University Lisbon.
Previous research from the team reported the levels of consumption of ultra-processed foods in the UK, which are the highest in Europe for both adults and children. The team also found that higher consumption of ultra-processed foods was associated with a greater risk of developing obesity and type 2 diabetes in UK adults, and a greater weight gain in UK children extending from childhood to young adulthood.
Dr. Eszter Vamos, lead senior author for the study, from Imperial College London’s School of Public Health, said, “This study adds to the growing evidence that ultra-processed foods are likely to negatively impact our health including our risk for cancer. Given the high levels of consumption in UK adults and children, this has important implications for future health outcomes.
“Although our study cannot prove causation, other available evidence shows that reducing ultra-processed foods in our diet could provide important health benefits. Further research is needed to confirm these findings and understand the best public health strategies to reduce the widespread presence and harms of ultra-processed foods in our diet.”
Dr. Kiara Chang, first author for the study, from Imperial College London’s School of Public Health, said, “The average person in the UK consumes more than half of their daily energy intake from ultra-processed foods.
“This is exceptionally high and concerning as ultra-processed foods are produced with industrially derived ingredients and often use food additives to adjust color, flavor, consistency, texture, or extend shelf life.
“Our bodies may not react the same way to these ultra-processed ingredients and additives as they do to fresh and nutritious minimally processed foods. However, ultra-processed foods are everywhere and highly marketed with cheap price and attractive packaging to promote consumption. This shows our food environment needs urgent reform to protect the population from ultra-processed foods.”
The World Health Organization and the United Nations’ Food and Agriculture Organization has previously recommended restricting ultra-processed foods as part of a healthy sustainable diet.
There are ongoing efforts to reduce ultra-processed food consumption around the world, with countries such as Brazil, France and Canada updating their national dietary guidelines with recommendations to limit such foods. Brazil has also banned the marketing of ultra-processed foods in schools. There are currently no similar measures to tackle ultra-processed foods in the UK.
Dr. Chang added, “We need clear front of pack warning labels for ultra-processed foods to aid consumer choices, and our sugar tax should be extended to cover ultra-processed fizzy drinks, fruit-based and milk-based drinks, as well as other ultra-processed products.
“Lower income households are particularly vulnerable to these cheap and unhealthy ultra-processed foods. Minimally processed and freshly prepared meals should be subsidized to ensure everyone has access to healthy, nutritious and affordable options.”
The researchers note that their study is observational, so does not show a causal link between ultra-processed foods and cancer due to the observational nature of the research. More work is needed in this area to establish a causal link.
About this diet and brain cancer research news
Original Research: The findings will appear in eClinicalMedicine
ER closure for Seaforth’s emergency department due to COVID-19 outbreak
Starting on Feb. 1, Seaforth’s emergency department will be closed in the overnight hours.
The Huron Perth Healthcare Alliance said due to “sudden health human resource shortages related to COVID-19,” the Seaforth Community Hospital’s emergency department will be closed from 5 p.m. to 7 a.m., from Feb. 1st to Feb. 6, when regular hours are expected to resume.
On Jan. 28, a COVID-19 outbreak was declared in Seaforth’s inpatient unit, closing all admissions to the unit. On Tuesday, a COVID-19 outbreak was declared at the Clinton General Hospital’s inpatient unit, also closing it to admissions.
In total, 10 people are in Huron-Perth hospitals dealing with COVID-19.
Two long-term care homes in the region are also dealing with COVID-19 outbreaks at the moment. Since Jan. 1, eight Huron-Perth residents, most of them over the age of 75, have died due to COVID-19, according to the Huron Perth Health Unit.
“I extend my condolences to the loved ones of these individuals,” said Dr. Miriam Klassen, medical officer of health for the Huron Perth Health Unit.
She added, “COVID-19 remains a serious illness for some people, especially those who are older. While we are seeing signs of improvement, it is important to keep taking actions to protect those who are most vulnerable to severe outcomes from this virus.”
GLP-1 Agonists Protected Kidneys in T2D With Advanced DKD
Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed.
- In patients with advanced diabetic kidney disease (DKD; estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73m2), treatment with a glucagon-like peptide-1 (GLP-1) agonist had a neutral effect on cardiovascular outcomes but significantly linked with preservation of kidney function and improved survival in a propensity-score matched, retrospective analysis of observational data from more than 2000 people with type 2 diabetes in Taiwan.
Why This Matters
- Cardiovascular disease is a leading cause of mortality in people with type 2 diabetes and among those with chronic kidney disease.
- GLP-1 agonists reduce all-cause mortality and cardiovascular death in people with type 2 diabetes, but their role in patients with advanced DKD is controversial.
- Research on the effect of GLP-1 agonists on cardiovascular outcomes in patients with advanced DKD is limited. Trials that have assessed GLP-1 agonists in people with type 2 diabetes have generally excluded those with advanced DKD and completely excluded those with end-stage kidney disease (eGFR < 30 mL/min/1.73m2).
- Treatment with GLP-1 agonists has been associated with a significant reduction in composite cardiovascular outcomes in people with type 2 diabetes and relatively fair kidney function (eGFR > 30 mL/min/1.73m2), but among people with type 2 diabetes and lower levels of kidney function, research has shown neutral composite cardiovascular outcomes levels. However, limitations of previous studies include being mainly based on subgroup analysis or including a limited sample of patients.
- Retrospective analysis of observational data from nearly 9000 people in Taiwan with type 2 diabetes and an eGFR < 30 mL/min/1.73m2 who received a first prescription for a GLP-1 agonist or dipeptidyl peptidase 4 (DPP-4) inhibitor in 2012-2021 and had the data necessary for this analysis in their records.
- The data came from the largest multi-institutional electronic medical record database in Taiwan, which includes two medical centers and five general hospitals and information on more than 11 million patients, from 2001 to 2019.
- Researchers used propensity scoring to match 602 people treated with a GLP-1 agonist with 1479 people treated with a DPP-4 inhibitor.
- During a mean follow-up of 2.1 years, the rate of the composite cardiovascular outcome (cardiovascular death, myocardial infarction, and ischemic stroke) did not significantly differ between the GLP-1 agonist and DPP-4 inhibitor groups, with incidence rates of 13.0% and 13.8%, respectively, and a nonsignificant hazard ratio of 0.88. Rates of each of the three components of the composite endpoint also did not significantly differ between the two groups.
- Progression to end-stage kidney disease with dialysis was significantly lower in those treated with a GLP-1 agonist compared with a DPP-4 inhibitor, with incidence rates of 23.4% and 27.5%, respectively, and a significant hazard ratio of 0.72.
- The incidence of a greater than 50% drop in eGFR from baseline was 32.2% with GLP-1 agonist treatment compared to 35.9% with a DPP-4 inhibitor, with a significant hazard ratio of 0.74.
- Median time until patients needed new-onset dialysis was 1.9 years with GLP-1 agonist treatment and 1.3 years with DPP-4 inhibitor treatment, which was a significant difference.
- The rate of all-cause death was 18.4% with GLP-1 agonist treatment compared with 25.1% with DPP-4 inhibitor treatment, a hazard ratio of 0.71 that was significant.
- Because the study was a retrospective analysis of observational data it cannot prove causality.
- The study could be subject to residual confounding despite propensity-score matching.
- The data came from health records that could have included coding errors.
- Treatment compliance was unknown.
This is a summary of a preprint research study, “The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease,” by researchers in Taiwan on Research Square and provided to you by Medscape. This study has not yet been peer reviewed. The full text of the study can be found on researchsquare.com.
Lead image: One Photo/Dreamstime
© 2023 WebMD, LLC
Send comments and news tips to email@example.com.
Cite this: GLP-1 Agonists Protected Kidneys in Type 2 Diabetes With Advanced DKD – Medscape – Jan 31, 2023.
Racism: Examining Injustices of Canadian Society
Shorten Your Job Search by Writing a Compelling Value Proposition Letter — Part 1
Understanding the connection between sporting events and online gambling today
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Search for life on Mars accelerates as new bodies of water found below planet’s surface
Business21 hours ago
TSX, Wall Street futures fade as earnings dominate, Fed awaited
Investment21 hours ago
Lithium Americas stock rises on GM’s $650 million equity investment
Business10 hours ago
Stock market news live updates: Stocks wrap up strong January as Fed decision looms
Business18 hours ago
A shortage of pilots is making travel chaos in Canada even worse
Tech9 hours ago
Canadian discovery could help batteries last longer
Sports2 hours ago
Understanding the connection between sporting events and online gambling today
Sports8 hours ago
Jays Sign Chad Green
Art23 hours ago
Lydia Tár Is Not an Art Monster